Lina Schiffer

Lina Schiffer

Auto-generated profile, based on publicly available information

Lina Schiffer

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Open access
LSLina Schiffer
Lina Schiffer
LBLise Barnard
Lise Barnard
EBElizabeth S. Baranowski
Elizabeth S. Baranowski
LGLorna C. Gilligan
Lorna C. Gilligan
ATAngela E. Taylor
Angela E. Taylor
KSKarl-Heinz Storbeck
Karl-Heinz Storbeck
Advances in technology have allowed for the sensitive, specific, and simultaneous quantitative profiling of steroid precursors, bioactive steroids and inactive metabolites, facilitating comprehensive characterization of the serum and urine steroid metabolomes. The quantification of steroid panels is therefore gaining favor over quantification of single marker metabolites in the clinical and research laboratories. However, although the biochemical pathways for the biosynthesis and metabolism of steroid hormones are now well defined, a gulf still exists between this knowledge and its application to the measured steroid profiles. In this review, we present an overview of steroid hormone biosynthesis and metabolism by the liver and peripheral tissues, specifically highlighting the pathways linking and differentiating the serum and urine steroid metabolomes. A brief overview of the methodology used in steroid profiling is also provided.

1 April 2018 in Molecular and Cellular Endocrinology
Verified
Journal Article
Open access
LSLina Schiffer
Lina Schiffer
WAWiebke Arlt
Wiebke Arlt
KSKarl-Heinz Storbeck
Karl-Heinz Storbeck
Androgens play an important role in metabolic homeostasis and reproductive health in both men and women. Androgen signalling is dependent on androgen receptor activation, mostly by testosterone and 5α-dihydrotestosterone. However, the intracellular or intracrine activation of C19 androgen precursors to active androgens in peripheral target tissues of androgen action is of equal importance. Intracrine androgen synthesis is often not reflected by circulating androgens but rather by androgen metabolites and conjugates. In this review we provide an overview of human C19 steroid biosynthesis including the production of 11-oxygenated androgens, their transport in circulation and uptake into peripheral tissues. We conceptualise the mechanisms of intracrinology and review the intracrine pathways of activation and inactivation in selected human tissues. The contribution of liver and kidney as organs driving androgen inactivation and renal excretion are also highlighted. Finally, the importance of quantifying androgen metabolites and conjugates to assess intracrine androgen production is discussed.

11 July 2019 in Endocrine Reviews
Verified
Journal Article
Open access
KSKarl-Heinz Storbeck
Karl-Heinz Storbeck
LSLina Schiffer
Lina Schiffer
EBElizabeth S Baranowski
Elizabeth S Baranowski
VCVasileios Chortis
Vasileios Chortis
APAlessandro Prete
Alessandro Prete
CSCedric H L Shackleton
Cedric H L Shackleton
Steroid biosynthesis and metabolism are reflected by the serum steroid metabolome and, in even more detail, by the 24-hour urine steroid metabolome, which can provide unique insights into alterations of steroid flow and output indicative of underlying conditions. Mass spectrometry–based steroid metabolome profiling has allowed for the identification of unique multisteroid signatures associated with disorders of steroid biosynthesis and metabolism that can be used for personalized approaches to diagnosis, differential diagnosis, and prognostic prediction. Additionally, steroid metabolome analysis has been used successfully as a discovery tool, for the identification of novel steroidogenic disorders and pathways as well as revealing insights into the pathophysiology of adrenal disease. Increased availability and technological advances in mass spectrometry–based methodologies have refocused attention on steroid metabolome profiling and facilitated the development of high-throughput steroid profiling methods soon to reach clinical practice. Furthermore, steroid metabolomics, the combination of mass spectrometry–based steroid analysis with machine learning–based approaches, has facilitated the development of powerful customized diagnostic approaches. In this review, we provide a comprehensive up-to-date overview of the utility of steroid metabolome analysis for the diagnosis and management of inborn disorders of steroidogenesis and autonomous adrenal steroid excess in the context of adrenal tumors.

1 September 2017 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
LSLina Schiffer
Lina Schiffer
PKPunith Kempegowda
Punith Kempegowda
WAWiebke Arlt
Wiebke Arlt
MOMichael W O’reilly
Michael W O’reilly
Female androgen excess and male androgen deficiency manifest with an overlapping adverse metabolic phenotype, including abdominal obesity, insulin resistance, type 2 diabetes mellitus, non-alcoholic fatty liver disease and an increased risk of cardiovascular disease. Here, we review the impact of androgens on metabolic target tissues in an attempt to unravel the complex mechanistic links with metabolic dysfunction; we also evaluate clinical studies examining the associations between metabolic disease and disorders of androgen metabolism in men and women. We conceptualise that an equilibrium between androgen effects on adipose tissue and skeletal muscle underpins the metabolic phenotype observed in female androgen excess and male androgen deficiency. Androgens induce adipose tissue dysfunction, with effects on lipid metabolism, insulin resistance and fat mass expansion, while anabolic effects on skeletal muscle may confer metabolic benefits. We hypothesise that serum androgen concentrations observed in female androgen excess and male hypogonadism are metabolically disadvantageous, promoting adipose and liver lipid accumulation, central fat mass expansion and insulin resistance.

1 July 2015 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
LSLina Schiffer
Lina Schiffer
SASimone Anderko
Simone Anderko
FHFrank Hannemann
Frank Hannemann
AEAntje Eiden-Plach
Antje Eiden-Plach
RBRita Bernhardt
Rita Bernhardt

10 January 2023 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
LSLina Schiffer
Lina Schiffer
PKPunith Kempegowda
Punith Kempegowda
ASAlice J Sitch
Alice J Sitch
JAJoanne E Adaway
Joanne E Adaway
FSFozia Shaheen
Fozia Shaheen
WAWiebke Arlt
Wiebke Arlt
11-oxygenated androgens significantly contribute to the circulating androgen pool. Understanding the physiological variation of 11-oxygenated androgens and their determinants is essential for clinical interpretation, for example, in androgen excess conditions. We quantified classic and 11-oxygenated androgens in serum and saliva across the adult age and body mass index (BMI) range, also analyzing diurnal and menstrual cycle-dependent variation. Cross-sectional. Morning serum samples were collected from 290 healthy volunteers (125 men, 22-95 years; 165 women, 21-91 years). Morning saliva samples were collected by a sub-group (51 women and 32 men). Diurnal saliva profiles were collected by 13 men. Twelve women collected diurnal saliva profiles and morning saliva samples on 7 consecutive days during both follicular and luteal menstrual cycle phases. Serum and salivary steroids were quantified by liquid chromatography–tandem mass spectrometry profiling assays. Serum classic androgens decreased with age-adjusted BMI, for example, %change kg/m2 for 5α-dihydrotestosterone: men −5.54% (95% confidence interval (CI) −8.10 to −2.98) and women −1.62% (95%CI −3.16 to −0.08). By contrast, 11-oxygenated androgens increased with BMI, for example, %change kg/m2 for 11-ketotestosterone: men 3.05% (95%CI 0.08-6.03) and women 1.68% (95%CI −0.44 to 3.79). Conversely, classic androgens decreased with age in both men and women, while 11-oxygenated androgens did not. Salivary androgens showed a diurnal pattern in men and in the follicular phase in women; in the luteal phase, only 11-oxygenated androgens showed diurnal variation. Classic androgens decrease while active 11-oxygenated androgens increase with increasing BMI, pointing toward the importance of adipose tissue mass for the activation of 11-oxygenated androgens. Classic but not 11-oxygenated androgens decline with age.